BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J. Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma. Biologics 2016;10:139-48. [PMID: 27703327 DOI: 10.2147/BTT.S87402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol 2019; 25(38): 5732-5772 [PMID: 31636470 DOI: 10.3748/wjg.v25.i38.5732] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 42] [Article Influence: 14.7] [Reference Citation Analysis]
2 Hutchings CJ, Colussi P, Clark TG. Ion channels as therapeutic antibody targets. MAbs 2019;11:265-96. [PMID: 30526315 DOI: 10.1080/19420862.2018.1548232] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
3 Kamgar-Dayhoff P, Brelidze TI. Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment. Oncotarget 2021;12:1406-26. [PMID: 34262651 DOI: 10.18632/oncotarget.28010] [Reference Citation Analysis]